From:  Transurethral laser ablation using 980-nm diode laser for recurrent non-muscle invasive bladder cancer

 Comparison of intraoperative and postoperative adverse events between TULA and TURBT.

Perioperative adverse eventsTRUBT, n (%)TULA, n (%)
Dysuria2 (8.3)0
Hematuria after operation1 (4.2)0
Liver dysfunction1 (4.2)0
Urinary tract infection1 (4.2)0
Bladder perforation1 (4.2)0